Suppr超能文献

完全缓解的急性白血病患者全身照射和骨髓移植后的白内障:欧洲血液和骨髓移植组的一项研究

Cataracts after total body irradiation and bone marrow transplantation in patients with acute leukemia in complete remission: a study of the European Group for Blood and Marrow Transplantation.

作者信息

Belkacemi Y, Labopin M, Vernant J P, Prentice H G, Tichelli A, Schattenberg A, Boogaerts M A, Ernst P, Della Volpe A, Goldstone A H, Jouet J P, Verdonck L F, Locasciulli A, Rio B, Ozsahin M, Gorin N C

机构信息

Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation, Paris, France.

出版信息

Int J Radiat Oncol Biol Phys. 1998 Jun 1;41(3):659-68. doi: 10.1016/s0360-3016(98)00077-7.

Abstract

PURPOSE

Advances in bone marrow transplantation (BMT) have consistently improved long-term survival. Therefore, evaluation of late complications such as cataracts is of paramount importance.

METHODS AND MATERIALS

We analyzed data of 2149 patients from the EBMT registry. A cohort of 1063 patients were evaluable for survival and ophthalmologic status after transplant for acute leukemia (AL) in first or second complete remission. Conditioning therapy included either single-dose total body irradiation (STBI) or fractionated TBI (FTBI) grouped in different dose rates (low: LDR < or = 0.04 Gy/min; high: HDR > 0.04 Gy/min).

RESULTS

The overall 10-year estimated cataract incidence (ECI) was 50%. It was 60% in the STBI group, 43% in the FTBI group < or = 6 fractions, and 7% in the FTBI group > 6 fractions (p < 10(-4)). It was significantly lower (30%) in the LDR than in the HDR groups (59%;p < 10(-4)). Patients receiving heparin for veno-occlusive disease prophylaxis had fewer cataracts than those who did not (10-year ECI: 33% vs. 53%, respectively;p = 0.04). The 10-year ECI was 65% in the allogeneic vs. 46% in the autologous BMT patients (p = 0.0018). Factors independently associated with an increased risk of cataract were an older age (> 23 years), higher dose rate (> 0.04 Gy/min), allogeneic BMT, and steroid administration (> 100 days). The use of FTBI was associated with a decreased risk of cataract. Heparin administration was a protective factor in patients receiving STBI. In terms of cataract surgery, the unfavorable factors for requiring surgery were: age > 23 yr, STBI, dose rate > 0.04 Gy/min, chronic graft-vs.-host disease (cGvHD), and absence of heparin administration. Among the patients who required cataract surgery (111 out of 257), secondary posterior capsular opacification was observed in 15.7%.

CONCLUSION

High dose rate and STBI are the main risk factors for cataract development and the need for surgery, and the administration of heparin has a protective role in cataractogenesis.

摘要

目的

骨髓移植(BMT)技术的进步持续提高了长期生存率。因此,评估白内障等晚期并发症至关重要。

方法与材料

我们分析了欧洲血液与骨髓移植登记处(EBMT)登记的2149例患者的数据。对1063例首次或第二次完全缓解的急性白血病(AL)患者进行移植后生存及眼科状况评估。预处理方案包括单剂量全身照射(STBI)或分次全身照射(FTBI),并根据不同剂量率分组(低剂量率:LDR≤0.04 Gy/min;高剂量率:HDR>0.04 Gy/min)。

结果

总体10年估计白内障发病率(ECI)为50%。STBI组为6%,FTBI组≤6次分割时为43%,FTBI组>6次分割时为7%(p<10⁻⁴)。低剂量率组(LDR)显著低于高剂量率组(HDR)(30%对59%;p<10⁻⁴)。接受肝素预防静脉闭塞性疾病的患者白内障较少(10年ECI分别为33%和53%;p = 0.04)。异基因BMT患者的10年ECI为65%,自体BMT患者为46%(p = 0.0018)。与白内障风险增加独立相关的因素包括年龄较大(>23岁)、高剂量率(>0.04 Gy/min)、异基因BMT和类固醇使用时间较长(>100天)。使用FTBI与白内障风险降低相关。肝素给药是接受STBI患者的保护因素。就白内障手术而言,需要手术的不利因素包括:年龄>23岁、STBI、剂量率>0.04 Gy/min、慢性移植物抗宿主病(cGvHD)和未使用肝素。在需要进行白内障手术的患者中(257例中的111例),观察到15.7%的患者发生了后囊膜混浊。

结论

高剂量率和STBI是白内障发生及手术需求的主要危险因素,肝素给药在白内障形成中具有保护作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验